Protocadherin-16 (PCDH16 or DCHS1) Antibody - FFPE Validated

Scientific Overview

This antibody supports experimental designs that examine Protocadherin-16 with interpretable controls and clear contrasts. Protocadherin-16 is a contact-site protein that shapes barrier properties and signaling at the cell surface. Plan positive and negative controls that match your model system, including perturbations expected to shift the target.

In some datasets and protocols, it is referenced by the gene symbol DCHS1.

Research Relevance

Junction proteins are frequently analyzed during differentiation, stress responses, and changes in cell polarity. Time course design can be decisive when regulation is transient or compartment dependent.

Because cellular networks are interconnected, changes in this target may coincide with shifts in related pathways, trafficking behavior, or structural remodeling. Planar polarity studies may connect this target to directional signaling and cytoskeletal alignment.

When building a narrative around the target, it helps to track:

• comparative profiling across cell states or perturbations
• co-localization patterns with cytoskeletal elements
• changes in complex assembly with scaffold or adaptor proteins

Application-Specific Context

This fixed-section oriented version is intended for paraffin-embedded tissue, where crosslinking and retrieval steps can shape epitope accessibility. Think about how preparation affects epitope accessibility, and interpret patterns alongside morphology and compartment markers as needed. Align controls to the expected direction of change to support confident interpretation.

When interpreting Protocadherin-16, consider whether changes track with compartment identity, cell density, or perturbation timing; these factors can influence apparent signal without implying a direct causal link.

Use the fixed-section option to keep Protocadherin-16 analysis aligned with planned contrasts and endpoints.